Mutant Forms of Growth Factor-binding Protein-2 Reverse BCR-ABL-induced Transformation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1995 Nov 21

PMID 7479904

Citations 21

Authors

M L Gishizky

D Cortez

A M Pendergast

Affiliations

Soon will be listed here.

Abstract

Growth factor-binding protein 2 (Grb2) is an adaptor protein that links tyrosine kinases to Ras. BCR-ABL is a tyrosine kinase oncoprotein that is implicated in the pathogenesis of Philadelphia chromosome (Ph1)-positive leukemias. Grb2 forms a complex with BCR-ABL and the nucleotide exchange factor Sos that leads to the activation of the Ras protooncogene. In this report we demonstrate that Grb2 mutant proteins lacking amino- or carboxyl-terminal src homology SH3 domains suppress BCR-ABL-induced Ras activation and reverse the oncogenic phenotype. The Grb2 SH3-deletion mutant proteins bind to BCR-ABL and do not impair tyrosine kinase activity. Expression of the Grb2 SH3-deletion mutant proteins in BCR-ABL-transformed Rat-1 fibroblasts and in the human Ph1-positive leukemic cell line K562 inhibits their ability to grow as foci in soft agar and form tumors in nude mice. Furthermore, expression of the Grb2 SH3-deletion mutants in K562 cells induced their differentiation. Because Ras plays an important role in signaling by receptor and nonreceptor tyrosine kinases, the use of interfering mutant Grb2 proteins may be applied to block the proliferation of other cancers that depend in part on activated tyrosine kinases for growth.

Citing Articles

Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors.

Ikeda D, Chi S, Uchiyama S, Nakamura H, Guo Y, Yamauchi N Int J Mol Sci. 2022; 23(11).

PMID: 35682627 PMC: 9180585. DOI: 10.3390/ijms23115950.

The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia.

Liu Y, Jang H, Zhang M, Tsai C, Maloney R, Nussinov R Biophys J. 2022; 121(12):2251-2265.

PMID: 35651316 PMC: 9279350. DOI: 10.1016/j.bpj.2022.05.030.

Investigating Cell Signaling with Gene Expression Datasets.

Wachira J, Hughes-Darden C, Nkwanta A CourseSource. 2020; 6.

PMID: 32855998 PMC: 7449260. DOI: 10.24918/cs.2019.1.

Comparative RNA-Seq transcriptome analyses reveal dynamic time-dependent effects of Fe, O, and Si irradiation on the induction of murine hepatocellular carcinoma.

Nia A, Khanipov K, Barnette B, Ullrich R, Golovko G, Emmett M BMC Genomics. 2020; 21(1):453.

PMID: 32611366 PMC: 7329445. DOI: 10.1186/s12864-020-06869-4.

Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial.

Ohanian M, Tari Ashizawa A, Garcia-Manero G, Pemmaraju N, Kadia T, Jabbour E Lancet Haematol. 2018; 5(4):e136-e146.

PMID: 29550383 PMC: 11840760. DOI: 10.1016/S2352-3026(18)30021-8.

References

Ridley A, Hall A . The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992; 70(3):389-99. DOI: 10.1016/0092-8674(92)90163-7. View

Lowenstein E, Daly R, Batzer A, Li W, Margolis B, Lammers R . The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992; 70(3):431-42. DOI: 10.1016/0092-8674(92)90167-b. View

Muller A, Young J, Pendergast A, Pondel M, Landau N, Littman D . BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol. 1991; 11(4):1785-92. PMC: 359845. DOI: 10.1128/mcb.11.4.1785-1792.1991. View

Bruder J, Heidecker G, Rapp U . Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 1992; 6(4):545-56. DOI: 10.1101/gad.6.4.545. View

Rosenberg N, Witte O . The viral and cellular forms of the Abelson (abl) oncogene. Adv Virus Res. 1988; 35:39-81. DOI: 10.1016/s0065-3527(08)60708-3. View

Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci P . Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 1994; 13(4):764-73. PMC: 394874. DOI: 10.1002/j.1460-2075.1994.tb06319.x. View

Dickson B, Sprenger F, Morrison D, Hafen E . Raf functions downstream of Ras1 in the Sevenless signal transduction pathway. Nature. 1992; 360(6404):600-3. DOI: 10.1038/360600a0. View

Ridley A, PATERSON H, Johnston C, Diekmann D, Hall A . The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 1992; 70(3):401-10. DOI: 10.1016/0092-8674(92)90164-8. View

Renshaw M, McWhirter J, Wang J . The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol Cell Biol. 1995; 15(3):1286-93. PMC: 230351. DOI: 10.1128/MCB.15.3.1286. View

10.

Cussac D, Frech M, Chardin P . Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline-rich motifs. EMBO J. 1994; 13(17):4011-21. PMC: 395321. DOI: 10.1002/j.1460-2075.1994.tb06717.x. View

11.

Kabarowski J, Allen P, Wiedemann L . A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J. 1994; 13(24):5887-95. PMC: 395564. DOI: 10.1002/j.1460-2075.1994.tb06934.x. View

12.

Cortez D, Kadlec L, Pendergast A . Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol. 1995; 15(10):5531-41. PMC: 230804. DOI: 10.1128/MCB.15.10.5531. View

13.

Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M . C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A. 1994; 91(8):3443-7. PMC: 43593. DOI: 10.1073/pnas.91.8.3443. View

14.

Seedorf K, Kostka G, Lammers R, Bashkin P, Daly R, Burgess W . Dynamin binds to SH3 domains of phospholipase C gamma and GRB-2. J Biol Chem. 1994; 269(23):16009-14. View

15.

Anafi M, Gazit A, Zehavi A, Ben-Neriah Y, Levitzki A . Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate. Blood. 1993; 82(12):3524-9. View

16.

Pendergast A, Quilliam L, Cripe L, Bassing C, Dai Z, Li N . BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell. 1993; 75(1):175-85. View

17.

Lozzio C, LOZZIO B . Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975; 45(3):321-34. View

18.

Fukazawa H, Li P, Yamamoto C, Murakami Y, Mizuno S, Uehara Y . Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro. Biochem Pharmacol. 1991; 42(9):1661-71. DOI: 10.1016/0006-2952(91)90500-5. View

19.

Clark S, Stern M, Horvitz H . C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature. 1992; 356(6367):340-4. DOI: 10.1038/356340a0. View

20.

Afar D, Goga A, McLaughlin J, Witte O, Sawyers C . Differential complementation of Bcr-Abl point mutants with c-Myc. Science. 1994; 264(5157):424-6. DOI: 10.1126/science.8153630. View